Schema Therapy (ST) has emerged as a promising intervention for Borderline Personality Disorder (BPD), targeting maladaptive schemas and core emotional needs. This meta-analysis of randomized controlled trials (RCTs) evaluates the efficacy of ST in reducing BPD symptoms and improving overall functioning in individuals with BPD. Through a comprehensive review of the literature, the meta-analysis synthesizes effect sizes from RCTs assessing the effectiveness of ST compared to control conditions (e.g., treatment as usual, other psychotherapies) in targeting core symptoms of BPD, including emotional dysregulation, identity disturbance, interpersonal difficulties, and self-harm behaviors. Additionally, it examines potential moderators of treatment outcomes, such as treatment duration, mode of delivery (individual vs. group), therapist experience, and participant characteristics (e.g., age, comorbidities), to better understand the factors influencing the effectiveness of ST for BPD.
This article are supported by WELI Scientific.